40 results on '"Farzaneh-Far, Ramin"'
Search Results
2. Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States
3. Long-Term Outcome of Incomplete Revascularization After Percutaneous Coronary Intervention in SCAAR (Swedish Coronary Angiography and Angioplasty Registry)
4. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial
5. Relation of Whole Blood n-3 Fatty Acid Levels to Exercise Parameters in Patients With Stable Coronary Artery Disease (from the Heart and Soul Study)
6. Relation of β-Blocker Use With Frequency of Hospitalization for Heart Failure in Patients With Left Ventricular Diastolic Dysfunction (from the Heart and Soul Study)
7. Relation of Obesity to Heart Failure Hospitalization and Cardiovascular Events in Persons With Stable Coronary Heart Disease (from the Heart and Soul Study)
8. Prognostic value of electrocardiographic detection of unrecognized myocardial infarction in persons with stable coronary artery disease: data from the Heart and Soul Study
9. Usefulness of Noninvasive Estimate of Pulmonary Vascular Resistance to Predict Mortality, Heart Failure, and Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease (from the Heart and Soul Study)
10. Accuracy of Doppler-Estimated Pulmonary Vascular Resistance in Patients Before Liver Transplantation
11. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease
12. Thinking outside the box
13. Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults
14. First-degree atrioventricular block is associated with heart failure and death in persons with stable coronary artery disease: data from the Heart and Soul Study
15. Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: Design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post–Percutaneous Coronary Intervention (RIVER-PCI) trial
16. Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study.
17. Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment.
18. Left-Ventricular Power-to-Mass Ratio at Peak Exercise Predicts Mortality, Heart Failure, and Cardiovascular Events in Patients with Stable Coronary Artery Disease: Data from the Heart and Soul Study
19. Nitric oxide and the liver
20. Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
21. Body mass index is negatively associated with telomere length: a collaborative cross-sectional meta-analysis of 87 observational studies.
22. Change in Leukocyte Telomere Length Predicts Mortality in Patients with Stable Coronary Heart Disease from the Heart and Soul Study.
23. Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy.
24. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.
25. Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN-TIMI 36 Trial.
26. Physical Fitness and Risk for Heart Failure and Coronary Artery Disease.
27. Physical Fitness and Telomere Length in Patients with Coronary Heart Disease: Findings from the Heart and Soul Study.
28. Depression and leukocyte telomere length in patients with coronary heart disease: data from the Heart and Soul Study.
29. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: The Heart and Soul Study
30. A Functional Polymorphism in Renalase (Glu37Asp) Is Associated with Cardiac Hypertrophy, Dysfunction, and Ischemia: Data from the Heart and Soul Study.
31. Telomere Length Trajectory and Its Determinants in Persons with Coronary Artery Disease: Longitudinal Findings from the Heart and Soul Study.
32. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study
33. Lack of association of chromosome 9p21.3 genotype with cardiovascular structure and function in persons with stable coronary artery disease: The Heart and Soul Study
34. Development of an Echocardiographic Risk-Stratification Index to Predict Heart Failure in Patients With Stable Coronary Artery Disease: The Heart and Soul Study.
35. Cysteinyl-leukotrienes and the liver
36. Hydroxychloroquine: A Treatable Cause of Cardiomyopathy
37. Clinical problem-solving. Thinking outside the box.
38. The spectrum of complement C9 staining in lupus nephritis.
39. PROGNOSTIC SIGNIFICANCE OF INTERMEDIATE QRS DURATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
40. CORRELATION BETWEEN LEUKOCYTE TELOMERE LENGTH AND DRUG ELUTING STENT STRUT COVERAGE BY OPTICAL COHERENCE TOMOGRAPHY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.